Search results
Found 10583 matches for
Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.
MSc in Experimental and Translational Therapeutics
For more information about the MSc in Experimental Therapeutics, please visit the page link below